| Literature DB >> 35556173 |
Paolo Pesce1, Maria Menini2, Giovanni Ugo3, Francesco Bagnasco2, Mario Dioguardi4, Giuseppe Troiano4.
Abstract
OBJECTIVES: The detrimental effect of tobacco smoking on periodontal health is well known, while the effect of electronic cigarette on periodontal parameters has been less investigated. The aim of the present systematic review was to compare periodontal indices in three categories of patients: traditional cigarette smokers (TS), e-cigarette smokers (ES), and non-smokers (NS).Entities:
Keywords: Network meta-analysis; Smokers; Systematic review; Tobacco; e-cigarette
Mesh:
Year: 2022 PMID: 35556173 PMCID: PMC9276554 DOI: 10.1007/s00784-022-04531-9
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Fig. 1Flowchart of the included studies
Main information on the included studies - NS
| Pub year | Title | Country | NF total | M/F | Age | Standard deviation | PI non-smokers % | Standard deviation | BOP non-smokers % | Standard deviation | PD non-smokers (mm) | Standard deviation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | Comparison of periodontal parameters and self-perceived oral symptoms among cigarette smokers, individuals vaping electronic cigarettes, and never-smokers | Saudi Arabia | 30 | Male | 40,7 | 1,6 | 21,4 | 2.8 | 27.5 | 3.2 | 0.57 | 0.03 |
| 2018 | Clinical and radiographic periodontal status and whole salivary cotinine. IL-1β and IL-6 levels in cigarette- and waterpipe-smokers and E-cig users | Saudi Arabia | 38 | Male | 41.6 | 4.5 | 23 | 0.004 | 37.4 | 6.4 | 1.4 | 0.1 |
| 2018 | Impact of cigarette smoking and vaping on the outcome of full-mouth ultrasonic scaling among patients with gingival inflammation: a prospective study | Saudi Arabia | 31 | Male | 32.6 | 3.5 | 46.3 | 5.2 | 38.2 | 6.5 | 4.2 | 0.3 |
| 2019 | Clinical periodontal status and gingival crevicular fluid cytokine profile among cigarette-smokers. electronic-cigarette users and never-smokers | Saudi Arabia | 45 | 124 males/11females | 40.6 | 3.3 | 18.2 | 2.45 | 28.4 | 1.61 | 1.6 | 0.23 |
| 2020 | Comparison of self-rated oral symptoms and periodontal status among cigarette smokers and individuals using electronic nicotine delivery systems | Saudi Arabia | 26 | Male | 33.5 | 1.4 | 4.2 | 0.5 | 22.1 | 3.3 | 1.5 | 0.2 |
Main information on the included studies - TS
| Pub year | Title | FUM total | Age | Standard deviation | Duration of habit (years) | Standard deviation | Daily frequency | Standard deviation | PI smokers % | Standard Deviation | BOP smokers % | Standard Deviation | PD smokers (mm) | Standard Deviation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | Comparison of periodontal parameters and self-perceived Oral symptoms among cigarette smokers. individuals vaping electronic cigarettes. and never-Smokers | 33 | 41.3 | 2.8 | 5.4 | 1.6 | 13.3 | 2.6 | 52.1 | 6.6 | 5.8 | 0.8 | 6.52 | 1.3 |
| 2018 | Clinical and radiographic periodontal status and whole salivary cotinine. IL-1β and IL-6 levels in cigarette- and waterpipe-smokers and E-cig users | 39 | 42.4 | 5.6 | 17.2 | 2.5 | 16.2 | 2.5 | 49.1 | 0.4 | 19.5 | 4.2 | 4.6 | 0.5 |
| 2018 | Impact of cigarette smoking and vaping on the outcome of full-mouth ultrasonic scaling among patients with gingival inflammation: a prospective study | 30 | 36.4 | 2.8 | 10.4 | 1.8 | 9.3 | 4.6 | 49.4 | 7.3 | 17.2 | 3.3 | 5.2 | 0.4 |
| 2019 | Clinical periodontal status and gingival crevicular fluid cytokine profile among cigarette-smokers. electronic-cigarette users and never-smokers | 46 | 44.2 | ± 3.5 | 14.2 | ± 0.6 | 42.1 | 1.36 | 10.6 | 1.56 | 5.3 | 0.43 | ||
| 2020 | Comparison of self-rated oral symptoms and periodontal status among cigarette smokers and individuals using electronic nicotine delivery systems | 28 | 33.3 | 1.2 | 6.1 | 0.5 | 39.3 | 8.2 | 12.1 | 3.6 | 4.2 | 0.2 |
Main information on the included studies - ES
| Pub year | Title | Study design | Country | ELEC total | Age | Standard deviation | Duration of habits (years) | Standard deviation) | Daily frequency | Standard deviation | PI e-cig smokers % | Standard Deviation | BOP e-cig smokers % | Standard deviation | PD e-cig smokers (mm) | Standard deviation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | Comparison of periodontal parameters and self-perceived oral symptoms among cigarette smokers. Individuals vaping electronic cigarettes and never-smokers | Comparative study | Saudi Arabia | 31 | 37.6 | 2.1 | 2.2 | 0.2 | 6.8 | 0.8 | 23.3 | 3.4 | 4.6 | 2.9 | 2.82 | 0.07 |
| 2018 | Clinical and radiographic periodontal status and whole salivary cotinine. IL-1β and IL-6 levels in cigarette- and waterpipe-smokers and E-cig users | Comparative Study | Saudi Arabia | 37 | 29.3 | 1.6 | 3.1 | 0.4 | 9.2 | 1.4 | 43.5 | 0.08 | 16.4 | 2.5 | 1.8 | 0.2 |
| 2018 | Impact of cigarette smoking and vaping on the outcome of full-mouth ultrasonic scaling among patients with gingival inflammation: a prospective study | Prospective study | Saudi Arabia | 28 | 32.5 | 4.8 | 3.1 | 0.4 | 12.5 | 0.8 | 43.5 | 5.6 | 11.6 | 4.5 | 4.6 | 0.2 |
| 2019 | Clinical periodontal status and gingival crevicular fluid cytokine profile among cigarette-smokers. electronic-cigarette users and never-smokers | Comparative Study | Saudi Arabia | 44 | 36.5 | 1.7 | 9.4 | 2.6 | 33.4 | 2.3 | 12.2 | 1.39 | 2.5 | 0.27 | ||
| 2020 | Comparison of self-rated oral symptoms and periodontal status among cigarette smokers and individuals using electronic nicotine delivery systems | Comparative Study | Saudi Arabia | 26 | 31.6 | 2.4 | 0.9 | 0.2 | 30.2 | 8.5 | 25.6 | 6.2 | 11.5 | 0.8 | 1.5 | 0.3 |
Risk of BIAS evaluation
| Fawad et al. | Sameer et al. | Shatha et al. | Munerah et al. | Fahim et al. | |
|---|---|---|---|---|---|
| 1. Was the research question or objective in this paper clearly stated? | Y | Y | Y | Y | Y |
| 2. Was the study population clearly specified and defined? | Y | N | Y | Y | Y |
| 3. Was the participation rate of eligible persons at least 50%? | Y | CD | CD | CD | CD |
| 4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | Y | CD | CD | CD | CD |
| 5. Was a sample size justification, power description, or variance and effect estimates provided? | Y | Y | Y | Y | Y |
| 6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? | NA | NA | Y | NA | NA |
| 7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | NA | NA | Y | NA | NA |
| 8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)? | NA | NA | NA | NA | NA |
| 9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | Y | Y | Y | Y | Y |
| 10. Was the exposure(s) assessed more than once over time? | NA | NA | Y | NA | NA |
| 11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | Y | Y | Y | Y | Y |
| 12. Were the outcome assessors blinded to the exposure status of participants? | Y | Y | Y | N | Y |
| 13. Was loss to follow-up after baseline 20% or less? | NA | NA | Y | NA | NA |
| 14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | N | N | N | N | N |
CD, cannot determine; NA, not applicable; NR, not reported
Fig. 2Network geometry plot
Fig. 3Interval plot for probing depth
Fig. 4SUCRA ranking for probing depth
Fig. 5Interval plot for plaque index
Fig. 6SUCRA ranking for plaque index
Fig. 7Interval plot for bleeding on probing
Fig. 8SUCRA ranking for bleeding on probing